{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:30:39Z","timestamp":1694727039576},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,7,5]],"date-time":"2005-07-05T00:00:00Z","timestamp":1120521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1007\/s00198-005-1965-6","type":"journal-article","created":{"date-parts":[[2005,7,4]],"date-time":"2005-07-04T17:14:04Z","timestamp":1120497244000},"page":"217-224","source":"Crossref","is-referenced-by-count":10,"title":["Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study"],"prefix":"10.1007","volume":"17","author":[{"given":"W. P.","family":"Olszynski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. S.","family":"Davison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ioannidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. A.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. G.","family":"Josse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. M.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J.","family":"Sebaldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Tenenhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. H.","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. D.","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,7,5]]},"reference":[{"key":"1965_CR1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s001980070050","volume":"11","author":"Tenenhouse","year":"2000","unstructured":"Tenenhouse A, Joseph L, Kreiger N, Poliquin S, Murray TM, Blondeau L, Berger C, Hanley DA, Prior JC (2000) Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 11:897\u2013904","journal-title":"Osteoporos Int"},{"key":"1965_CR2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s001980070066","volume":"11","author":"Jackson","year":"2000","unstructured":"Jackson SA, Tenenhouse A, Robertson L (2000) Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int 11:680\u2013687","journal-title":"Osteoporos Int"},{"key":"1965_CR3","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1359\/jbmr.1998.13.12.1915","volume":"13","author":"Melton","year":"1998","unstructured":"Melton LJ III, Atkinson EJ, O\u2019Connor MK, O\u2019Fallon WM, Riggs BL (1998) Bone density and fracture risk in men. J Bone Miner Res 13:1915\u20131923","journal-title":"J Bone Miner Res"},{"key":"1965_CR4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2105\/AJPH.80.3.326","volume":"80","author":"Kellie","year":"1990","unstructured":"Kellie SE, Brody JA (1990) Sex-specific and race-specific hip fracture rates. Am J Public Health 80:326\u2013328","journal-title":"Am J Public Health"},{"key":"1965_CR5","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(98)09075-8","volume":"353","author":"Center","year":"1999","unstructured":"Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353:878\u2013882","journal-title":"Lancet"},{"key":"1965_CR6","first-page":"4358","volume":"81","author":"Katznelson","year":"1996","unstructured":"Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A (1996) Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 81:4358\u20134365","journal-title":"J Clin Endocrinol Metab"},{"key":"1965_CR7","first-page":"1966","volume":"84","author":"Snyder","year":"1999","unstructured":"Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Holmes JH, Dlewati A, Staley J, Santanna J, Kapoor SC, Attie MF, Haddad JG Jr, Strom BL (1999) Effect of testosterone treatment on bone mineral density in men over 65\u00a0years of age. J Clin Endocrinol Metab 84:1966\u20131972","journal-title":"J Clin Endocrinol Metab"},{"key":"1965_CR8","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2362.2001.00836.x","volume":"31","author":"Pietschmann","year":"2001","unstructured":"Pietschmann P, Kudlacek S, Grisar J, Spitzauer S, Woloszczuk W, Willvonseder R, Peterlik M (2001) Bone turnover markers and sex hormones in men with idiopathic osteoporosis. Eur J Clin Invest 31:444\u2013451","journal-title":"Eur J Clin Invest"},{"key":"1965_CR9","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJM200008313430902","volume":"343","author":"Orwoll","year":"2000","unstructured":"Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604\u2013610","journal-title":"N Engl J Med"},{"key":"1965_CR10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/PL00004182","volume":"11","author":"Ho","year":"2000","unstructured":"Ho YV, Frauman AG, Thomson W, Seeman E (2000) Effects of alendronate on bone density in men with primary and secondary osteoporosis. Osteoporos Int 11:98\u2013101","journal-title":"Osteoporos Int"},{"key":"1965_CR11","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1210\/jcem.86.11.7988","volume":"86","author":"Ringe","year":"2001","unstructured":"Ringe JD, Faber H, Dorst A (2001) Alendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study. J Clin Endocrinol Metab 86:5252\u20135255","journal-title":"J Clin Endocrinol Metab"},{"key":"1965_CR12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/ard.56.4.280a","volume":"56","author":"Geusens","year":"1997","unstructured":"Geusens P, Vanhoof J, Raus J, Dequeker J, Nijs J, Joly J (1997) Treatment with etidronate for men with idiopathic osteoporosis. Ann Rheum Dis 56:280","journal-title":"Ann Rheum Dis"},{"key":"1965_CR13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W","volume":"44","author":"Adachi","year":"2001","unstructured":"Adachi JD, Saag KG, Delmas PD, Liberman UA, Emkey RD, Seeman E, Lane NE, Kaufman JM, Poubelle PE, Hawkins F, Correa-Rotter R, Menkes CJ, Rodriguez-Portales JA, Schnitzer TJ, Block JA, Wing J, McIlwain HH, Westhovens R, Brown J, Melo-Gomes JA, Gruber BL, Yanover MJ, Leite MO, Siminoski KG, Nevitt MC, Sharp JT, Malice MP, Dumortier T, Czachur M, Carofano W, Daifotis A (2001) Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum 44:202\u2013211","journal-title":"Arthritis Rheum"},{"key":"1965_CR14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","volume":"339","author":"Saag","year":"1998","unstructured":"Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 339:292\u2013299","journal-title":"N Engl J Med"},{"key":"1965_CR15","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199708073370603","volume":"337","author":"Adachi","year":"1997","unstructured":"Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, Kendler DL, Lentle B, Olszynski W, Ste-Marie LG, Tenenhouse A, Chines AA (1997) Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 337:382\u2013387","journal-title":"N Engl J Med"},{"key":"1965_CR16","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K","volume":"42","author":"Cohen","year":"1999","unstructured":"Cohen S, Levy RM, Keller M, Boling E, Emkey RD, Greenwald M, Zizic TM, Wallach S, Sewell KL, Lukert BP, Axelrod DW, Chines AA (1999) Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum 42:2309\u20132318","journal-title":"Arthritis Rheum"},{"key":"1965_CR17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002230001146","volume":"67","author":"Wallach","year":"2000","unstructured":"Wallach S, Cohen S, Reid DM, Hughes RA, Hosking DJ, Laan RF, Doherty SM, Maricic M, Rosen C, Brown J, Barton I, Chines AA (2000) Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int 67:277\u2013285","journal-title":"Calcif Tissue Int"},{"key":"1965_CR18","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1359\/jbmr.2000.15.6.1006","volume":"15","author":"Reid","year":"2000","unstructured":"Reid DM, Hughes RA, Laan RF, Sacco-Gibson NA, Wenderoth DH, Adami S, Eusebio RA, Devogelaer JP (2000) Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J Bone Miner Res 15:1006\u20131013","journal-title":"J Bone Miner Res"},{"key":"1965_CR19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00223-001-1060-8","volume":"69","author":"Reid","year":"2001","unstructured":"Reid DM, Adami S, Devogelaer JP, Chines AA (2001) Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy. Calcif Tissue Int 69:242\u2013247","journal-title":"Calcif Tissue Int"},{"key":"1965_CR20","first-page":"41","volume":"21","author":"Sebaldt","year":"1996","unstructured":"Sebaldt RJ, Adachi JD (1996) Canadian database of osteoporosis and osteopenia patients (CANDOO). Canadian organization for the advancement of computers in healthcare proceedings 21:41\u201344","journal-title":"Canadian organization for the advancement of computers in healthcare proceedings"},{"key":"1965_CR21","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1359\/jbmr.1997.12.9.1463","volume":"12","author":"Hui","year":"1997","unstructured":"Hui SL, Gao S, Zhou XH, Johnston CC, Jr., Lu Y, Gluer CC, Grampp S, Genant H (1997) Universal standardization of bone density measurements: a method with optimal properties for calibration among several instruments. J Bone Miner Res 12:1463\u20131470","journal-title":"J Bone Miner Res"},{"key":"1965_CR22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF01774010","volume":"5","author":"Faulkner","year":"1995","unstructured":"Faulkner KG, McClung MR (1995) Quality control of DXA instruments in multicenter trials. Osteoporos Int 5:218\u2013227","journal-title":"Osteoporos Int"},{"key":"1965_CR23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s001980070082","volume":"11","author":"Crilly","year":"2000","unstructured":"Crilly RG, Sebaldt RJ, Hodsman AB, Adachi JD, Brown JP, Goldsmith CH, Hanley DA, Olszynski WO, Ste-Marie LG, Stephenson GF (2000) Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial density response in patients with osteoporosis. Osteoporos Int 11:607\u2013614","journal-title":"Osteoporos Int"},{"key":"1965_CR24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/biomet\/63.3.581","volume":"63","author":"Rubin","year":"1976","unstructured":"Rubin D (1976) Inference and missing data. Biometrika 63:581\u2013590","journal-title":"Biometrika"},{"key":"1965_CR25","doi-asserted-by":"crossref","unstructured":"Schafer JL (1997) Analysis of incomplete multivariate data. 2\u20136. Chapman & Hall, London","DOI":"10.1201\/9781439821862"},{"key":"1965_CR26","first-page":"S1","volume":"167","author":"Brown","year":"2002","unstructured":"Brown JP, Josse RG (2002) 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167:S1\u201334","journal-title":"CMAJ"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-005-1965-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-005-1965-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-005-1965-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T03:58:47Z","timestamp":1586318327000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-005-1965-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,5]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["1965"],"URL":"https:\/\/doi.org\/10.1007\/s00198-005-1965-6","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,5]]}}}